Authors

Erin Hunter
Latest Article

Study shows gender disparities in CKD detection and treatment

“We observed profound differences in the detection work up and management of chronic kidney disease suggesting suboptimal care among women,” said Juan Jesus Carrero, PharmD, PhD.

Bladder Cancer Advocacy Network
Latest Article

Bladder Cancer Advocacy Network (BCAN) announces $600,000 in funding to accelerate breakthroughs in bladder cancer research

Awardees are being recognized for creative approaches to accelerating progress in bladder cancer research.

Elizabeth Pan, MD
Latest Article

GNRH agonists vs antagonists in prostate cancer: How to choose

Many factors play into decision-making process when weighing agents.

Kenton H. Steele, Esq
Kenton H. Steele, Esq

Steele is an attorney in the Columbus, Ohio, office of Reminger Co, LPA. He specializes in malpractice defense and insurance litigation.

Latest Article

Malpractice Consult: How attorneys successfully cross-examine expert witnesses

"Effective cross-examination can create an implication that an expert’s opinions are motivated by bias or self-interest, rather than a neutral evaluation of the facts. This is frequently accomplished by highlighting the fact that experts are paid for time spent reviewing a case and testifying," writes Kenton H. Steele, Esq.

Christopher B. Anderson MD, MPH

Anderson is an assistant professor of urology at NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York.

Latest Article

Management of hormone-naïve oligometastatic prostate cancer

Growing evidence supports the existence of an intermediate metastatic disease state.

Nicholas W. Eyrich, MS
Latest Article

Integrating video visits into urologic training

"Now is the time for programs to leverage their existing telehealth platforms and practices for trainee education while continuing to serve patients," the authors write.

Media Department, US Urology Partners
Latest Article

US Urology Partners Names Healthcare Visionary Raoul S. Concepcion, MD, as Chief Science Officer

Concepcion is editor-in-chief of Urology Times' sister publication, Urologists in Cancer Care.

Brian Myre, MD

Myre is a medical oncologist with Elmhurst Hematology Oncology Group in Elmhurst, Illinois.

Latest Article

Letter: Declassifying Gleason 6 as a cancer would do more harm than good

"We feel a more appropriate approach would be to retain true Gleason 6 as a cancer of extremely low metastatic potential requiring close follow-up," write Harris et al.

Jason M. Broderick and Cheryl Guttman Krader, BS, Pharm
Latest Article

PINNACLE trial aims to confirm pilot success with BPH drug-coated balloon catheter

The drug-coated balloon catheter system is being compared with a sham device in a double-blinded randomized trial.

Rebekah Bernard, MD
Latest Article

A physician’s advice for defusing patient anger

Rebekah Bernard, MD, provides tips for improving interactions with patients who are angry.

Max Schloemann
Latest Article

Urology Practice advice: prioritize billing and coding oversight

When a miscoded procedure is the result of substantial negligence or fraud, it can be detrimental to a medical practice or physician.

Sujith Puskoor, DO
Latest Article

PARP inhibitors: Treating mCRPC from a genetic basis

Treatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.

Solaris Health
Latest Article

Urologic Consultants has joined Solaris Health

Leading West Michigan practice now affiliated with nation’s largest urological healthcare management company

Andrew G. McIntosh, MD
Latest Article

Radical nephrectomy before or after systemic therapy for mRCC

Recent research has revived the controversy regarding the role of cytoreductive nephrectomy in this setting.

Kirsty Mackay
Brandon Daniell
Latest Article

How text messaging can be a valuable tool for your practice

Here are seven ways texting can improve healthcare revenue and decrease costs.

Bryan S. Sack, MD
Latest Article

Integrating video visits into urologic training

"Now is the time for programs to leverage their existing telehealth platforms and practices for trainee education while continuing to serve patients," the authors write.

Kyle Doherty
Latest Article

New Drug Application initiated with FDA for TAR-200 for NMIBC

The NDA is supported by data from cohort 2 of the phase 2b SunRISe-1 trial.

Chris Baird
Latest Article

Online reviews are crucial to maintaining a thriving health care practice

Independent health care practices rely on online ratings and reviews to attract new patients and establish themselves as leading, recognizable providers in their community.

Cynthia Sener, MBA
Latest Article

Managing your online reputation in health care

While online reviews are critical in any industry, patient expectations are simply different when it comes to health care.

University Hospitals
Latest Article

Register Today! UH Urology Institute’s Fall Symposiums

University Hospitals Urology Institute is excited to announce that this coming fall, the department is hosting 2 educational courses in cutting-edge urologic specialties: female sexual health and gender care.

Allina Health Cancer Institute
Latest Article

Allina Health Cancer Institute 2022 Symposium reimagines cancer care

The symposium brings together clinicians devoted to solving the disease of cancer and the many challenges associated with it.

Clint Cary, MD, MBA, MPH
Latest Article

The role of surgery continues to evolve in seminoma

"RPLND is an attractive option for those who prefer to avoid chemotherapy," write Jiping Zeng, MD; Timothy A. Masterson, MD; and Clint Cary, MD, MPH, MBA.

Richard G. Harris, MD, FACS

Harris is a urologic oncologist with UroPartners LLC in Chicago, Illinois.

Latest Article

Letter: Declassifying Gleason 6 as a cancer would do more harm than good

"We feel a more appropriate approach would be to retain true Gleason 6 as a cancer of extremely low metastatic potential requiring close follow-up," write Harris et al.

Ron Panarotti
Latest Article

2025 year in review: Breakthroughs in urologic oncology during a year of unprecedented awareness

"If 2025 showed us anything, it is the power of combining scientific progress with public engagement," writes Michael S. Cookson, MD, MMHC, FACS.

Jamie Cesanek
Latest Article

Abiraterone-based triplet boosts survival in de novo mCSPC

Findings from the PEACE-1 trial published in the Lancet showed that adding abiraterone acetate and prednisone to androgen-deprivation therapy and docetaxel improved overall survival in patients with de novo metastatic castration-sensitive prostate cancer.

Michael Parisi
Latest Article

Smaller medical practices increasingly targeted for cyber attacks

Patient data is so valuable — and smaller providers are more vulnerable — that hackers are increasingly targeting physician groups.

Hal H. Atkinson, MD, MS
Latest Article

The aging surgeon: A geriatrician's perspective

"We all need to revisit meaningful methods for ongoing assurance of competency specific to our fields of medicine and surgery across the physician career span," writes Hal H. Atkinson, MD, MS.

Nichole Tucker
Latest Article

Novel intravesical drug delivery systems explored in bladder cancer

"TAR-200 is a sort of a pretzel device. It's a novel drug delivery mechanism that's placed inside the bladder for sustained release of gemcitabine," explains Siamak Daneshmand, MD.

Joan Naidorf, DO
Latest Article

Expert advice on improving interactions with difficult patients

“Patients will never change, and demanding family members will never change. The solution to the problem is to manage the way we think about them,” writes Joan Naidorf, DO.